Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy.
Storey RF, Angiolillo DJ, Patil SB, Desai B, Ecob R, Husted S, Emanuelsson H, Cannon CP, Becker RC, Wallentin L. Storey RF, et al. Among authors: desai b. J Am Coll Cardiol. 2010 Oct 26;56(18):1456-62. doi: 10.1016/j.jacc.2010.03.100. J Am Coll Cardiol. 2010. PMID: 20832963 Free article. Clinical Trial.
Impact of gastric acid-suppressing therapies on platelet reactivity in patients with coronary artery disease treated with clopidogrel: results of a pharmacodynamic study.
Pham JP, Ueno M, Tello-Montoliu A, Ferreiro JL, Tomasello SD, Dharmashankar K, Kodali M, Seecheran N, Capodanno D, Desai B, Bass TA, Angiolillo DJ. Pham JP, et al. Among authors: desai b. J Am Coll Cardiol. 2011 Sep 20;58(13):1396-8. doi: 10.1016/j.jacc.2011.06.031. J Am Coll Cardiol. 2011. PMID: 21920272 Free article. No abstract available.
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
Angiolillo DJ, Jakubowski JA, Ferreiro JL, Tello-Montoliu A, Rollini F, Franchi F, Ueno M, Darlington A, Desai B, Moser BA, Sugidachi A, Guzman LA, Bass TA. Angiolillo DJ, et al. Among authors: desai b. J Am Coll Cardiol. 2014 Sep 9;64(10):1005-14. doi: 10.1016/j.jacc.2014.06.1170. J Am Coll Cardiol. 2014. PMID: 25190236 Free article.
Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized study.
Tello-Montoliu A, Tomasello SD, Ferreiro JL, Ueno M, Seecheran N, Desai B, Kodali M, Charlton RK, Box LC, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ. Tello-Montoliu A, et al. Among authors: desai b. J Am Coll Cardiol. 2012 May 8;59(19):1681-7. doi: 10.1016/j.jacc.2011.12.039. J Am Coll Cardiol. 2012. PMID: 22554598 Free article. Clinical Trial.
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus.
Tello-Montoliu A, Ferreiro JL, Kodali MK, Ueno M, Tomasello SD, Rollini F, Capodanno D, Darlington A, Patel R, Desai B, Guzman LA, Bass TA, Angiolillo DJ. Tello-Montoliu A, et al. Among authors: desai b. J Thromb Thrombolysis. 2013 Jul;36(1):14-7. doi: 10.1007/s11239-012-0828-1. J Thromb Thrombolysis. 2013. PMID: 23143668 Clinical Trial.
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, Bernardo E, Zenni MM, Guzman LA, Bass TA, Costa MA. Angiolillo DJ, et al. Among authors: desai b. Circulation. 2007 Feb 13;115(6):708-16. doi: 10.1161/CIRCULATIONAHA.106.667741. Epub 2007 Jan 29. Circulation. 2007. PMID: 17261652 Clinical Trial.
Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
Angiolillo DJ, Bernardo E, Palazuelos J, Desai B, Weisberg I, Alfonso F, Guzman LA, Hernández-Antolin R, Zenni MZ, Macaya C, Fernandez-Ortiz A, Bass TA. Angiolillo DJ, et al. Among authors: desai b. Thromb Haemost. 2008 Jan;99(1):161-8. doi: 10.1160/TH07-09-0562. Thromb Haemost. 2008. PMID: 18217149 Clinical Trial.
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
Angiolillo DJ, Capranzano P, Goto S, Aslam M, Desai B, Charlton RK, Suzuki Y, Box LC, Shoemaker SB, Zenni MM, Guzman LA, Bass TA. Angiolillo DJ, et al. Among authors: desai b. Eur Heart J. 2008 Sep;29(18):2202-11. doi: 10.1093/eurheartj/ehn287. Epub 2008 Jun 21. Eur Heart J. 2008. PMID: 18567918 Clinical Trial.
530 results